Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans

Human Gene Therapy

Volumn 24, Issue 4, 2013, Pages 431-442

  Parzych, Elizabeth M ^a   Li, Hua ^a   Yin, Xiangfan ^a   Liu, Qin ^a   Wu, Te Lang ^b   Podsakoff, Gregory M ^c   High, Katherine A ^c   Levine, Matthew H ^d   Ertl, Hildegund C J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; ORGAN TRANSPLANTATION; T LYMPHOCYTE; VIRUS CAPSID;

ADULT; AGED; ANTIGENS, VIRAL; CAPSID; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION IMMUNOLOGY;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

EID: 84876512832     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.246     Document Type: Article

References (32)

1. Araki, K., Turner, A.P., Shaffer, V.O., et al. (2009). mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112.
2. Ardehali, H., Volmar, K., Roberts, C., et al. (2001). Fatal disseminated adenoviral infection in a renal transplant patient. Transplantation 71, 998-999.
3. Atchison, R.W., Casto, B.C., and Hammon, W.M. (1965). Adenovirus-associated defective virus particles. Science 149, 754-756.
4. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
5. Boutin, S., Monteilhet, V., Veron, P., et al. (2010). Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors. Hum. Gene Ther. 21, 704-712.
6. Chen, J., Wu, Q., Yang, P., et al. (2006). Determination of specific CD4 and CD8 T cell epitopes after AAV2-and AAV8-hF.IX gene therapy. Mol. Ther. 13, 260-269.
7. Glenn, J. (1981). Cytomegalovirus infections following renal transplantation. Rev. Infect Dis. 3, 1151-1178.
8. Grigoryev, Y.A., Kurian, S.M., Avnur, Z., et al. (2010). Decon-voluting post-transplant immunity: Cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells. PLoS One 5, e13358.
9. Gummert, J.F., Ikonen, T., and Morris, R.E. (1999). Newer im-munosuppressive drugs: A review. J. Am. Soc. Nephrol. 10, 1366-1380.
10. Hickman, S.P., and Turka, L.A. (2005). Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 1713-1721.
11. Kiani, A., Rao, A., and Aramburu, J. (2000). Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12, 359-372.
12. Li, H., Lasaro, M.O., Jia, B., et al. (2011). Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol. Ther. 19, 2021-30.
13. Lucas, K.G., Pollok, K.E., and Emanuel, D.J. (1997). Post-transplant EBV induced lymphoproliferative disorders. Leuk. Lymphoma 25, 1-8.
14. Manno, C.S., Pierce, G.F., Arruda, V.R., et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347.
15. + T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13, 419-422.
16. Mingozzi, F., Meulenberg, J.J., Hui, D.J., et al. (2009). AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells. Blood 114, 2077-2086.
17. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat. Rev. Genet. 12, 341-355.
18. + T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int. Immunol. 10, 311-323.
19. Mueller, C., and Flotte, T.R. (2008). Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858-863.
20. Nathwani, A.C., Gray, J.T., McIntosh, J., et al. (2007). Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 109, 1414-1421.
21. Nathwani, A.C., Tuddenham, E.G., Rangarajan, S., et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357-2365.
22. Ritter, M.L., and Pirofski, L. (2009). Mycophenolate mofetil: Effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl. Infect. Dis. 11, 290-297.
23. Roederer, M., Nozzi, J.L., and Nason, M.C. (2011). SPICE: Exploration and analysis of post-cytometric complex multivari-ate datasets. Cytometry A 79A, 167-174.
24. Schnepp, B.C., Jensen, R.L., Chen, C.L., et al. (2005). Characterization of adeno-associated virus genomes isolated from human tissues. J. Virol. 79, 14793-14803.
25. Scroggs, M.W., Wolfe, J.A., Bollinger, R.R., and Sanfilippo, F. (1987). Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. Arch. Pathol. Lab. Med. 111, 983-987.
26. Sehgal, S.N. (2003). Sirolimus: Its discovery, biological properties, and mechanism of action. Transplant. Proc. 35, 7S-14S.
27. Shroff, P., Mehta, R.S., Chinen, J., et al. (2012). Presentation of atopic disease in a large cohort of pediatric liver transplant recipients. Pediatr. Transplant. 16, 379-384.
28. Vandenberghe, L.H., Wilson, J.M., and Gao, G. (2009). Tailoring the AAV vector capsid for gene therapy. Gene Ther. 16, 311-319.
29. Wang, L., Calcedo, R., Nichols, T.C., et al. (2005). Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 105, 3079-3086.
30. Wang, L., Wang, H., Bell, P., et al. (2010). Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol. Ther. 18, 118-125.
31. Weitzman, M.D., and Linden, R.M. (2011). Adeno-associated virus biology. Methods Mol. Biol. 807, 1-23.
32. Yalkinoglu, A.O., Heilbronn, R., Burkle, A., et al. (1988). DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 48, 3123-3129.